Shannon Eagan is a partner at Cooley LLP.
Shannon represents corporations and individuals in complex disputes and litigation, internal corporate investigations and Securities and Exchange Commission investigations and actions. Shannon successfully defended a drug development company and its officers and directors in a victory that validated how many life science companies disclose clinical data to the public before the Ninth Circuit Court of Appeals. She also served on the trial team for the first defendant to obtain an acquittal in a stock-options backdating prosecution. Shannon has handled a wide variety of other complex litigation matters, including securities litigation, high-stakes licensing disputes, commercial contract litigation, corporate governance disputes and merger litigation. Her clients have included companies in the life sciences, hardware, software, semiconductor, food and public utility industries. Shannon serves as Northern California head of Cooley’s business litigation practice.
Recent matters include:
- Rigel Pharmaceuticals, in securities litigation lawsuit resulting in a major victory for the client and an important decision by the 9th US Circuit Court of Appeals with significant implications for all publicly traded life sciences companies.
- Annie’s Homegrown, in connection with securities litigation lawsuit and merger-related litigation.
- Several life science companies, in connection with licensing disputes and claims against contract research organizations.
- Several companies and individuals, in connection with internal and SEC investigations into their accounting practices, the Foreign Corrupt Practices Act and internal controls.
- Public companies and their boards, in litigation brought by shareholders challenging a merger and alleging breaches of fiduciary duty.
- Private company’s special committee, in connection with internal investigation into fraud by CEO.